1 Min Read
May 10 (Reuters) - Actinium Pharmaceuticals Inc
* Actinium Pharmaceuticals receives clearance from Health Canada to initiate pivotal phase 3 sierra trial of Iomab-B Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.